Penumbra Inc
PEN294.440USD
+1.600+0.55%
Horário de mercado （ET）Cotações atrasadas em 15 min
11.39BValor de mercado
812.88P/L TTM
Mais detalhes de Penumbra Inc Empresa
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
Informações da empresa
Código da empresaPEN
Nome da EmpresaPenumbra Inc
Data de listagemSep 18, 2015
Fundado em2004
CEOMr. Adam Elsesser, J.D.
Número de funcionários4500
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 18
EndereçoOne Penumbra Place
CidadeALAMEDA
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal94502
Telefone15109952486
Sitehttps://www.penumbrainc.com/
Código da empresaPEN
Data de listagemSep 18, 2015
Fundado em2004
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
901.49K
+4.18%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
302.26K
-3.82%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
53.58K
-0.36%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
Ms. Bridget O'Rourke
Ms. Bridget O'Rourke
Independent Director
Independent Director
4.96K
-1.00%
Ms. Surbhi Sarna
Ms. Surbhi Sarna
Independent Director
Independent Director
3.15K
-1.84%
Ms. Maggie S. Yuen
Ms. Maggie S. Yuen
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Thomas C. (Tom) Wilder, III
Mr. Thomas C. (Tom) Wilder, III
Presiding Independent Director
Presiding Independent Director
--
--
Mr. Harpreet S. Grewal
Mr. Harpreet S. Grewal
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
901.49K
+4.18%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
302.26K
-3.82%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
53.58K
-0.36%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
Ms. Bridget O'Rourke
Ms. Bridget O'Rourke
Independent Director
Independent Director
4.96K
-1.00%
Detalhamento da receita
Moeda: USDTempo de atualização: dom, 6 de abr
Moeda: USDTempo de atualização: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Thrombectomy
815.48M
68.26%
Embolization and Access
379.14M
31.74%
Por RegiãoUSD
Nome
Receita
Proporção
United States
902.07M
75.51%
International
292.55M
24.49%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Thrombectomy
815.48M
68.26%
Embolization and Access
379.14M
31.74%
Acionista
Tempo de atualização: sáb, 26 de abr
Tempo de atualização: sáb, 26 de abr
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
Fidelity Management & Research Company LLC
12.53%
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
9.03%
Champlain Investment Partners, LLC
3.86%
T. Rowe Price Associates, Inc.
3.19%
Other
61.98%
Estatísticas dos acionistas
Acionista
Proporção
Fidelity Management & Research Company LLC
12.53%
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
9.03%
Champlain Investment Partners, LLC
3.86%
T. Rowe Price Associates, Inc.
3.19%
Other
61.98%
Tipo
Acionista
Proporção
Investment Advisor
50.51%
Investment Advisor/Hedge Fund
32.26%
Hedge Fund
4.42%
Individual Investor
3.42%
Research Firm
1.59%
Pension Fund
1.51%
Sovereign Wealth Fund
0.68%
Bank and Trust
0.54%
Private Equity
0.19%
Other
4.87%
Participação acionária institucional
Tempo de atualização: seg, 20 de jan
Tempo de atualização: seg, 20 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
838
36.86M
95.18%
-4.14M
2024Q4
834
37.02M
96.10%
-3.78M
2024Q3
813
37.33M
96.12%
-2.93M
2024Q2
796
37.57M
96.93%
+395.13K
2024Q1
777
35.67M
92.18%
-2.09M
2023Q4
759
36.33M
94.13%
-67.98K
2023Q3
737
35.15M
91.46%
-2.09M
2023Q2
719
36.20M
94.64%
-1.94M
2023Q1
681
37.31M
97.62%
-964.82K
2022Q4
661
36.89M
97.22%
+885.45K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Fidelity Management & Research Company LLC
4.85M
12.6%
-93.71K
-1.89%
Dec 31, 2024
The Vanguard Group, Inc.
3.64M
9.46%
-25.90K
-0.71%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
3.50M
9.08%
+25.93K
+0.75%
Dec 31, 2024
Champlain Investment Partners, LLC
1.50M
3.88%
-52.02K
-3.36%
Dec 31, 2024
T. Rowe Price Associates, Inc.
1.23M
3.21%
-702.67K
-36.27%
Dec 31, 2024
State Street Global Advisors (US)
1.20M
3.12%
-33.45K
-2.71%
Dec 31, 2024
Fidelity Institutional Asset Management
965.15K
2.51%
+16.18K
+1.71%
Dec 31, 2024
Elsesser (Adam)
985.33K
2.56%
+22.75K
+2.36%
Mar 19, 2025
William Blair Investment Management, LLC
883.10K
2.29%
-98.21K
-10.01%
Dec 31, 2024
RTW Investments L.P.
862.45K
2.24%
+66.70K
+8.38%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: dom, 6 de abr
Tempo de atualização: dom, 6 de abr
Nome
Proporção
Motley Fool Small-Cap Growth ETF
3.6%
First Trust Health Care Alphadex Fund
2.08%
First Trust Indxx Medical Devices ETF
1.89%
Congress SMid Growth ETF
1.87%
Putnam Sustainable Future ETF
1.67%
Tema Neuroscience and Mental Health ETF
1.58%
ROBO Global Healthcare Technology & Innovation ETF
1.56%
SPDR S&P Health Care Equipment ETF
1.53%
Zacks Focus Growth ETF
1.2%
iShares U.S. Medical Devices ETF
1.13%
Ver Mais
Motley Fool Small-Cap Growth ETF
Proporção3.6%
First Trust Health Care Alphadex Fund
Proporção2.08%
First Trust Indxx Medical Devices ETF
Proporção1.89%
Congress SMid Growth ETF
Proporção1.87%
Putnam Sustainable Future ETF
Proporção1.67%
Tema Neuroscience and Mental Health ETF
Proporção1.58%
ROBO Global Healthcare Technology & Innovation ETF
Proporção1.56%
SPDR S&P Health Care Equipment ETF
Proporção1.53%
Zacks Focus Growth ETF
Proporção1.2%
iShares U.S. Medical Devices ETF
Proporção1.13%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados